Share

    


Home / Search Results

Search Results

You searched for:

ACCC recently announced a collaboration with the Digital Medicine Society on a project to develop a risk prediction tool for cytokine release syndrome.
As immune checkpoint inhibitors have become the standard of care for eligible patients with NSCLC, frequent monitoring of irAEs as well as provider and patient education on the signs and symptoms of pneumonitis can ensure improved clinical outcomes for patients.
The Ohio State University Comprehensive Cancer Center developed the James Cancer Diagnostic Center, to deliver a comprehensive assessment of signs or symptoms of malignancy in a timely fashion.
ACCC Buzz had an opportunity to speak with Jonathan Govette, co-founder and chief operating officer at Oatmeal Health, to learn more about its virtual clinic and patient engagement services and cancer screenings.
ACCC conducted a comprehensive survey and a series of four focus groups to explore current attitudes, beliefs, and concerns related to multi-cancer early detection.
On September 16, the National Comprehensive Cancer Network convened experts and stakeholders in D.C. for a policy summit spotlighting today’s cancer screening and prevention landscape. Learn what speakers discussed, including what changes need to happen to create an equitable future for all people at risk—or not—for cancer.
Cancer and its treatment impact patients in many ways, beginning before a diagnosis and lasting long through survivorship, including one's sexual health. All of Me was created to bridge this communication gap between patients and providers.
To fill a care gap, The James Cancer Hospital opened a new set of front doors to its facility—The James Cancer Diagnostic Center—to ensure all patients with a concern for cancer could be quickly evaluated, even if they didn’t have a confirmed diagnosis.
With an aging U.S. population and a projected shortage of medical oncologists, oncology pharmacists and the critical support they provide in the management of patient symptoms and comorbidities is more important than ever.
Disparities in evaluation, management, and mortality persist in patient populations where bladder cancer is less common.
The COVID-19 pandemic has had a negative impact in the rate of cancer screening across various states in the United States. Louisiana, Delaware, Kentucky and Northern Michigan serve as vehicles for an analysis of the disparity in cancer screening rates, before and after the pandemic.
The second post in a three-blog series, ACCCBuzz shares how Carolina Blood and Cancer Care Associates' NOLA initiative is addressing access to care, clinical trials, biomarker testing, and more.
An expert ACCC Steering Committee shares 32 informed treatment and care delivery recommendations for the ideal care of patients with non-small cell lung cancer.
An integrated precision tracking program ensures proper follow-up care and surveillance for survivors of colorectal cancer.
Because of its growing retirement-age population and its unique location on a barrier island, The Outer Banks Hospital saw patients with lung cancer presenting at too late a stage for curative treatment. Learn how the hospital created an LDCT program and partnered with local providers and community cancer centers to identify patients with lung cancer at an earlier stage.
Lung cancer screenings are more effective and more affordable than ever before, but patient access still poses significant hurdles. Read how Levine Cancer Institute’s mobile lung LDCT unit brings lung screenings to underserved communities.
Through its Breast Care ACCESS Project, Summa Health redesigned its breast cancer care continuum to address disparities in treatment, reducing patient outmigration, increasing procedures and referrals, and lowering wait times.